中國軟件國際(00354.HK)簽約河南省人社廳 構建社保基金數智安全體系
格隆匯11月25日丨中國軟件國際(00354.HK)發佈公吿,公司憑藉在社保基金監管以及數據安全領域的深厚沉澱和信創系列產品適配、落地的全棧技術優勢,近日成功與河南省人力資源和社會保障廳(以下簡稱“河南省人社廳”)簽署金保工程二期社會保險基金監管子系統整體解決方案承建項目合同。本次合作,公司將以智能社保基金監管應用場景為牽引,助力河南省人社廳構建全新自主可控的社保基金監管系統,將河南省社保基金監管系統打造成技術領先、安全自主可控的信創新標杆項目,並以此次合作為基礎,持續推動國產化操作系統等信創技術、產品、組件在全國社保基金監管領域應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.